Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
investing
2
×
life sciences
national blog main
san francisco
san francisco blog main
san francisco top stories
startups
alphabet
ame cloud ventures
american diabetes association
boston top stories
broad institute of harvard and mit
brook byers
charles chu
clinical trials
clostridium difficile
colleen cutcliffe
computational biology
crispr
crispr cas14
deals
decheng capital
diabetes type 2
diagnostic
fda
google
infectious disease
inflammatory bowel disease
khosla ventures
kleiner perkins
mammoth biosciences
mayfield
mayo foundation
medical devices
medical foods
metformin
microbiome
national top stories
What
available
2
×
today
balance
based
big
bio
biome
biosciences
blood
cas
cheaper
crispr
develop
diabetes
diagnostics
expects
eyes
faster
food
healthy
hormone
include
intended
launch
leads
levels
mammoth
medical
pills
restore
set
shots
sugar
things
tiny
treatments
what’s
Language
unset
Current search:
investing
×
available
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
